Eckert & Ziegler SE (ETR:EUZ)
16.91
-0.27 (-1.57%)
Oct 17, 2025, 5:35 PM CET
Eckert & Ziegler SE Revenue
Eckert & Ziegler SE had revenue of 80.61 million EUR in the quarter ending June 30, 2025, with 3.66% growth. This brings the company's revenue in the last twelve months to 299.27 million, up 9.42% year-over-year. In the year 2024, Eckert & Ziegler SE had annual revenue of 295.85 million with 20.22% growth.
Revenue (ttm)
299.27M
Revenue Growth
+9.42%
P/S Ratio
3.54
Revenue / Employee
272.56K
Employees
1,085
Market Cap
1.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 295.85M | 49.76M | 20.22% |
Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
Dec 31, 2020 | 176.14M | -2.35M | -1.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bayer Aktiengesellschaft | 46.17B |
Siemens Healthineers AG | 23.38B |
Fresenius SE & Co. KGaA | 22.28B |
Merck KGaA | 21.22B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Redcare Pharmacy NV | 2.68B |
Fielmann Group AG | 2.40B |
Eckert & Ziegler SE News
- 5 weeks ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 5 weeks ago - EQS-News: Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47% - Wallstreet:Online
- 2 months ago - Eckert & Ziegler Earnings Surge in Early 2025 - Wallstreet:Online
- 2 months ago - EQS-News: Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025 - Wallstreet:Online
- 2 months ago - EQS-News: Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025 - Wallstreet:Online
- 2 months ago - EQS-News: Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 - Wallstreet:Online
- 2 months ago - EQS-News: Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation. - Wallstreet:Online
- 2 months ago - EQS-NVR: Eckert & Ziegler SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online